Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-01
2008-04-01
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S438000, C548S131000, C549S077000
Reexamination Certificate
active
10500811
ABSTRACT:
The present invention encompasses compounds of Formula (I) as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
REFERENCES:
patent: 4774251 (1988-09-01), Hirsch et al.
patent: 6437165 (2002-08-01), Mandala et al.
patent: 2446593 (2002-11-01), None
patent: 0 791 576 (1997-08-01), None
patent: WO 02/18395 (2002-03-01), None
Kiuchi, M., et al, Journal of Medicinal chemistry, American Chemical Society, vol. 43, pp. 2946-2961, XP 002271142, 2000.
Nicolaus B.J.R.: “Symbiotic approach to drug design”, Decision Making in Drug Research, 1983, pp. 173-186, XP002197412.
Doherty George A.
Hale Jeffrey J.
Li Zhen
Mills Sander G.
Anderson Rebecca
Krovatin William
Merck & Co. , Inc.
Yuro Raynard
LandOfFree
N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3940355